We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

32 hedge funds and large institutions have $3.64M invested in Cardiol Therapeutics in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,300% more call options, than puts

Call options by funds: $34K | Put options by funds: $1K

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

23% more funds holding

Funds holding: 26 → 32 (+6)

3.11% more ownership

Funds ownership: 7.69% → 10.8% (+3.1%)

25% less capital invested

Capital invested by funds: $4.88M → $3.64M (-$1.24M)

Holders
32
Holders Change
+6
Holders Change %
+23.08%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
3
Closed
5
Calls
$34K
Puts
$1K
Net Calls
+$33K
Net Calls Change
-$291K

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$671K
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$136K
3
Goldman Sachs
Goldman Sachs
New York
+$61.9K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$45.9K
5
Jane Street
Jane Street
New York
+$38.4K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$36K
2
Citadel Advisors
Citadel Advisors
Florida
-$28.2K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20K
4
Morgan Stanley
Morgan Stanley
New York
-$8.53K
5
PO
Private Ocean
California
-$3.35K
Name Holding Trade Value Shares
Change 		Change in
Stake
MI
1
MMCAP International
Cayman Islands
$1.71M – – –
AI
2
AdvisorShares Investments
Maryland
$733K +$671K +1,100,790 New
Mirae Asset Global Investments
3
Mirae Asset Global Investments
South Korea
$557K +$136K +223,478 +26%
TC
4
Tejara Capital
United Kingdom
$225K +$269K +440,626 New
VIA
5
Vident Investment Advisory
Georgia
$74.8K +$838 +1,375 +0.9%
Bank of Montreal
6
Bank of Montreal
Ontario, Canada
$61.2K +$45.9K +75,269 +511%
Goldman Sachs
7
Goldman Sachs
New York
$51.8K +$61.9K +101,500 New
Osaic Holdings
8
Osaic Holdings
Arizona
$38K +$31.6K +51,870 +227%
Jane Street
9
Jane Street
New York
$32.1K +$38.4K +63,073 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$26K – – –
MHIC
11
Marble Harbor Investment Counsel
Massachusetts
$18.8K – – –
Two Sigma Advisers
12
Two Sigma Advisers
New York
$18.3K – – –
TSS
13
Two Sigma Securities
New York
$17.1K +$20.5K +33,564 New
RSWM
14
Robertson Stephens Wealth Management
California
$14.2K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$13K -$2K -3,288 -11%
TRCT
16
Tower Research Capital (TRC)
New York
$11K +$11.5K +18,926 +536%
PO
17
Private Ocean
California
$7.73K -$3.35K -5,500 -27%
UBS Group
18
UBS Group
Switzerland
$5.62K +$5.49K +9,011 +451%
SG
19
StoneX Group
New York
$5.4K +$6.45K +10,586 New
TWC
20
TD Waterhouse Canada
Ontario, Canada
$4.97K – – –
VNA
21
Valley National Advisers
Pennsylvania
$3K – – –
FDCDDQ
22
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.45K – – –
Morgan Stanley
23
Morgan Stanley
New York
$2.29K -$8.53K -13,985 -76%
ASN
24
Advisory Services Network
Georgia
$1.76K +$2.11K +3,458 New
PSB
25
Piscataqua Savings Bank
New Hampshire
$1.53K +$1.83K +3,000 New
1
2

CRDL Hedge Fund Activity: Q4 2022 in Review

32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q4 2022, worth a combined $3.64M — down 25% from $4.88M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CRDL positions and 5 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $671K. The largest seller was Millennium Management, exiting entirely with an estimated $36K sold.

  • 32 institutional investors held Cardiol Therapeutics (CRDL) as of Q4 2022, up from 26 in Q3 2022.
  • Funds reported $3.64M of Cardiol Therapeutics stock for Q4 2022, down 25% quarter-over-quarter.
  • 11 funds opened new Cardiol Therapeutics positions in Q4 2022 and 5 closed out, a net change of +6 holders.
  • The largest Cardiol Therapeutics buyer in Q4 2022 was AdvisorShares Investments, an estimated $671K added.
  • The largest Cardiol Therapeutics seller in Q4 2022 was Millennium Management, an estimated $36K sold.

Based on aggregated 13F filings for Q4 2022.